COLL earnings call for the period ending September 30, 2020.
News & Analysis: Collegium Pharmaceutical
These two companies aren't reinventing the wheel, but they still have the potential for tremendous growth.
These three health-related businesses are well positioned to provide market-beating gains.
This is the story of an emerging healthcare company on its way to capturing a billion-dollar market opportunity.
COLL earnings call for the period ending June 30, 2020.
These are the two healthcare stocks that possess the best value for the greatest reward in May.
COLL earnings call for the period ending March 31, 2020.
A company making abuse-deterrent opioids and that's barely listed in any nation-wide opioid litigation is becoming a rising star despite the prescription overdose crisis.
COLL earnings call for the period ending December 31, 2019.
Investors aren't happy about the drugmaker's proposed senior convertible note offering.